REGENXBIO/ US75901B1070 /
| 2024-09-26 9:59:58 PM | Chg. -0.15 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 10.69USD | -1.38% | 21,009 Turnover: 224,569.63 |
-Bid Size: - | -Ask Size: - | 11.07 | 10.47 |
GlobeNewswire
08-12
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
07-24
Emerging Gene Therapies Signal Transformative Shift in Retinal Disorder Treatment, According to Sphe...
GlobeNewswire
07-10
Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Boa...
GlobeNewswire
06-24
Ophthalmologists Favor Genentech’s Vabysmo and Regeneron’s Eylea HD for Diabetic Macular Edema Treat...
GlobeNewswire
06-12
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
05-01
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire
04-29
Coave Therapeutics Showcases its ALIGATER™ Platform for Generating Conjugated AAV (coAAV) Vectors Ex...
GlobeNewswire
02-08
Stakes Are High for Regeneron's Eylea HD as Genentech's Vabysmo Continues to Gain Momentum, Promptin...
GlobeNewswire
2023-11-13
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-11-07
Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic In...
GlobeNewswire
2023-10-12
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicate...
GlobeNewswire
2022-03-10
Clearside Biomedical Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corp...
GlobeNewswire
2022-02-14
Clearside Biomedical’s Suprachoroidal Injection Platform Featured at the Angiogenesis, Exudation, an...
GlobeNewswire
2022-02-10
Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
GlobeNewswire
2022-02-02
Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at the Angiogenesis, Exudati...
GlobeNewswire
2021-11-16
Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy...
GlobeNewswire
2021-11-10
Clearside Biomedical Announces Third Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2021-11-03
Solid Biosciences Provides Third Quarter 2021 Business Update and Financial Results
GlobeNewswire
2021-11-02
Ultragenyx Reports Third Quarter 2021 Financial Results and Corporate Update
GlobeNewswire
2021-11-02
Pathway Development Consortium Releases Draft White Paper to Facilitate AAV Gene Therapy Development
GlobeNewswire
2021-10-13
Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Spec...
GlobeNewswire
2021-10-04
Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scien...
GlobeNewswire
2021-08-02
Ultragenyx Reports Second Quarter 2021 Financial Results and Corporate Update
